account_id none on file
legal_name Genenta Science S.p.A.
ticker GNTA
cik 1838716
domain genenta.com
linkedin_company_url https://www.linkedin.com/company/genenta
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 16 executives 11 family 0
why_nownone on file
callsnone on file
filings
healthcare industry, and elsewhere around the world, is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for medications.
filing / Apr 1, 2026 / receipt
cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize
filing / Apr 1, 2026 / receipt
Based on that evaluation, we, including our Chief Executive Officer and Chief Financial Officer, have concluded that our disclosure
filing / Apr 1, 2026 / receipt
51 square meters of office space (three (3) offices). The lease commenced in January 2020 and had a six (6) year initial term.
filing / Apr 1, 2026 / receipt
Beginning January 1, 2020, we entered into a six-year lease agreement for the use of office space in the OSR building. We paid OSR annual rent of approximately €15,000 in 2025 with a security deposit of €3,350.
filing / Apr 1, 2026 / receipt
Pierluigi Paracchi | 52 | Chief Executive Officer, Chairman of the Board of Directors, and General Manager | 2014
filing / Apr 1, 2026 / receipt
Francesco Galimi | 58 | Director, Acting Chief Medical Officer and Head of Development (4) | 2025
filing / Apr 1, 2026 / receipt
Miguel Maria Mutti | 51 | Director (1) (2) | 2025
filing / Apr 1, 2026 / receipt
Giacomoantonio Paracchi | 48 | Director (3) | 2025
filing / Apr 1, 2026 / receipt
Armon Reza Sharei | 38 | Director (1) (2) | 2024
filing / Apr 1, 2026 / receipt
Richard B. Slansky | 68 | Chief Financial Officer | 2021
filing / Apr 1, 2026 / receipt
Carlo-Alberto Nicchio | 51 | Chairman of the Board of Statutory Auditors | 2024
filing / Apr 1, 2026 / receipt
executives
| Adalberto Adriano Minazzi | Alternate auditor | - | receipt |
| Armon Reza Sharei | Director (1) (2) | - | receipt |
| Carlo-Alberto Nicchio | Chairman of the Board of Statutory Auditors | - | receipt |
| Francesco Galimi | Director, Acting Chief Medical Officer and Head of Development (4) | - | receipt |
| Giacomoantonio Paracchi | Director (3) | - | receipt |
| Giuseppe Gentile | Statutory auditor | - | receipt |
| Jacopo Doveri | Statutory auditor | - | receipt |
| Luca Domenico Maranzana | Alternate auditor | - | receipt |
| Miguel Maria Mutti | Director (1) (2) | - | receipt |
| Pierluigi Paracchi | Chief Executive Officer, Chairman of the Board of Directors, and General Manager | - | receipt |
| Richard B. Slansky | Chief Financial Officer | - | receipt |
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
slug genenta-science-s-p-a
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$